Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. - sprookjes - yvandenbroek - TriplyDB

Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects.

Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects.

http://www.wikidata.org/entity/Q33751565

about

Does Hsp60 Provide a Link between Mitochondrial Stress and Inflammation in Diabetes Mellitus?Recent advances in managing and understanding diabetic nephropathy The Toll of Vascular Insufficiency: Implications for the Management of Peripheral Arterial Disease Toll-like receptor activation: from renal inflammation to fibrosis The human gut microbiome and body metabolism: implications for obesity and diabetes Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signalling High Mobility Group Box-1: A Missing Link between Diabetes and Its Complications Metainflammation in Diabetic Coronary Artery Disease: Emerging Role of Innate and Adaptive Immune Responses Minireview: Emerging Concepts in Islet Macrophage Biology in Type 2 Diabetes Isolated Toll-like receptor transmembrane domains are capable of oligomerization Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus Expression of toll-like receptor 2 in glomerular endothelial cells and promotion of diabetic nephropathy by Porphyromonas gingivalis lipopolysaccharide.TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy.Toll-like receptor 2 and type 2 diabetes.TLR4 and Caveolin-1 in Monocytes Are Associated With Inflammatory Conditions in Diabetic Neuropathy Neutrophil and Monocyte Bactericidal Responses to 10 Weeks of Low-Volume High-Intensity Interval or Moderate-Intensity Continuous Training in Sedentary Adults MiR-30a targets IL-1α and regulates islet functions as an inflammation buffer and response factor.Diet-induced alterations in gut microflora contribute to lethal pulmonary damage in TLR2/TLR4-deficient mice.Hyperinsulinemia Down-Regulates TLR4 Expression in the Mammalian Heart.Toll-like receptors regulate B cell cytokine production in patients with diabetes.TLR4 and Insulin Resistance.Differential regulation of TLR4 expression in human B cells and monocytes.Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors.Regulation of inflammatory phenotype in macrophages by a diabetes-induced long noncoding RNA.Increased Toll-Like Receptors Activity and TLR Ligands in Patients with Autoimmune Thyroid Diseases.HMGB1 in health and disease.Expression of Toll-Like Receptor 4 in Glomerular Endothelial Cells under Diabetic Conditions.Thermodynamic contributions of single internal rA·dA, rC·dC, rG·dG and rU·dT mismatches in RNA/DNA duplexes.Effect of lipopolysaccharide on inflammation and insulin action in human muscle.Hyperglycemia induces Toll-like receptor-2 and -4 expression and activity in human microvascular retinal endothelial cells: implications for diabetic retinopathy Elevated muscle TLR4 expression and metabolic endotoxemia in human aging.Resveratrol ameliorates experimental periodontitis in diabetic mice through negative regulation of TLR4 signaling DPP-4 (CD26) inhibitor alogliptin inhibits atherosclerosis in diabetic apolipoprotein E-deficient mice.The chaperone balance hypothesis: the importance of the extracellular to intracellular HSP70 ratio to inflammation-driven type 2 diabetes, the effect of exercise, and the implications for clinical management.Toll-like receptor 4 upregulation by angiotensin II contributes to hypertension and vascular dysfunction through reactive oxygen species production The effects of antidepressants "fluoxetine and imipramine" on vascular abnormalities and Toll like receptor-4 expression in diabetic and non-diabetic rats exposed to chronic stress.Experimental hyperglycemia induces an increase of monocyte and T-lymphocyte content in adipose tissue of healthy obese women.Diabetes: impaired damage control Type 2 Diabetes Monocyte MicroRNA and mRNA Expression: Dyslipidemia Associates with Increased Differentiation-Related Genes but Not Inflammatory Activation.Pharmacological TLR4 Inhibition Protects against Acute and Chronic Fat-Induced Insulin Resistance in Rats

P2860

Q26740176-15B9B0D6-9CDA-440A-85A1-A35E052C945E Q26745900-D8FD9571-3868-4474-8F60-73AEE1E7568B Q26753079-4553F616-D2BA-4460-942B-E51ABF061755 Q26796639-F9DBFE51-6E0F-4F4C-BB26-08D97B6800BD Q26995303-A8153BB8-A829-4879-B3A0-65AA6C8DEA12 Q27661754-20A3021B-9A5E-4823-AC00-BBC51933F1B1 Q28066302-93AFE147-C481-4512-A666-C9D7469512E7 Q28075968-BC02688D-E4E4-4685-97F2-98CFCF2001DA Q28083768-D513D330-77FC-494F-8300-0435C1CAF971 Q28485183-751A4BD5-36A9-400A-8266-235A400E6AB1 Q33577386-AC8648E5-1925-48C1-A201-BDD3175C949E Q33623473-FAA5FD3E-0D5E-4B61-BD95-3C8E8548F565 Q33633050-1EF75ACC-E565-42C2-914A-639EC5AD1C5F Q33634951-A69F96AE-9F6F-4A41-B222-C0FFAAC9402A Q33648050-7ADC74BD-9327-4593-8F70-9A70350CE22B Q33800874-6CC0ABB6-5A1B-4CCA-A0EC-146E9AEFF9DC Q33903029-6058C660-15D4-4007-B24E-6C3F78FC5CCA Q33921242-6AD6FEA3-8755-46E7-9A31-BFEBAF8521AC Q33928779-2FCFECE9-7FD7-47FB-A4BF-7639B2741784 Q33954398-FC3E049D-64CE-4B31-BEB1-55E3440BCA9E Q34097407-53A98713-CE6B-4F50-A6B0-31D2428C8070 Q34361049-2BC035D2-DE46-4196-B619-EB3B3830A6B9 Q34501763-245C05AF-7C91-4568-939A-158F76128DD4 Q34545552-E03836E5-8EC4-4C9B-94F1-677BF302C806 Q34548024-455D9DF4-4A3E-494E-A25D-45F7C8F22825 Q34622835-369A755F-F8EF-423A-8CCC-778559236EF2 Q34647622-971666B8-217A-41AD-984D-B38DE4C7B63C Q34699840-B451D9C7-08AA-4889-8110-E62905AA8F95 Q34737898-0A2E4754-00A9-4A8D-8187-DF6F6551781F Q34950714-43752AA9-881A-42D1-9FA6-B503153AD6B5 Q35029353-211E7748-29AC-4528-B223-2851BD0D2940 Q35080161-A2258E1C-D158-40E2-8B7A-22B33EBECE19 Q35161203-8582010F-B621-48ED-8A55-2171DF7F867E Q35169987-005669D0-2D7F-45BD-878C-11B4D4ABE25C Q35219493-09D883E5-2A02-4DAC-99F9-B77D791FB9EF Q35235141-EC5A52E4-CD44-43F5-920D-3E093EA98F7D Q35493888-098580CD-4941-497D-9594-41AB89BFF1F2 Q35587364-29BBADCD-56CC-44EA-92BD-297F8A3D48C5 Q35665925-7F5EF70B-D637-40B3-8393-0F46BCFCA94E Q35702671-785562BB-564A-44DD-8002-6DCC639122BA

P2860

Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects.

http://www.wikidata.org/entity/Q33751565

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Increased toll-like receptor ( ...... osed type 2 diabetic subjects.

@ast

Increased toll-like receptor ( ...... osed type 2 diabetic subjects.

@en

type

label

Increased toll-like receptor ( ...... osed type 2 diabetic subjects.

@ast

Increased toll-like receptor ( ...... osed type 2 diabetic subjects.

@en

prefLabel

Increased toll-like receptor ( ...... osed type 2 diabetic subjects.

@ast

Increased toll-like receptor ( ...... osed type 2 diabetic subjects.

@en

P1433

Q33751565-0C00165A-7F02-45EE-9B16-C951945DAD3C

P1476

Q33751565-FB61D402-EF44-4995-B588-2097E8993E1D

P2093

Q33751565-3235A562-BC59-41C0-93CD-DBDB3D01A8AD

Q33751565-3363BF43-7273-4592-91EC-5084B8643FD3

Q33751565-4B609F29-3646-4388-B52A-4D98D89374DB

Q33751565-C1F48C24-98F8-4841-A1D0-6873302D6DF8

P2860

Q33751565-05C2EAE0-5A75-4B1B-8087-7819C5C78F7A

Q33751565-0BC17308-B155-4DC7-8C18-62589D628BF1

Q33751565-0BFFDE0F-1995-4EB1-B3C4-3C2D2403B9CE

Q33751565-0C26A8E1-D97A-4850-A749-CB79044F8174

Q33751565-17BF7F52-26FA-4433-B512-4F9A022E2471

Q33751565-2D4ADE4C-CA4F-435A-B1F2-D80361F25D71

Q33751565-3534FD69-5746-4AAB-A713-83DC47821B89

Q33751565-5B9696BD-8197-4C30-80D3-9FA4C0C2A2C6

Q33751565-661212AC-0B3D-49F1-96BF-4B46462D44D1

Q33751565-777373F9-DD71-42A6-84F6-8037E3C9D90F

P304

Q33751565-76CDCD94-0909-42BA-99EE-7F3FBA5BFEAB

P31

Q33751565-605CB838-ED54-465E-A3CF-288458E4E81E

P356

Q33751565-6D66ED00-1C1F-4A59-B81F-61159770316F

P407

Q33751565-A9B40C9D-F2BA-49EC-BF82-7F9CCD76F28D

P433

Q33751565-004F1EDA-C1AE-4FED-BD1A-E682C2817BE5

P478

Q33751565-0F3D2585-EFA8-4296-B579-3F30C59D5777

P577

Q33751565-93C63897-E108-495C-A506-B877C3B43CAB

P5875

Q33751565-18A0A058-4864-4FBA-B9B6-10FC3D8F2282

P698

Q33751565-A5B3DF47-8A64-49EA-A9EA-D1AE7358246B

P921

Q33751565-4bb94410-59aa-4023-a33c-3b3ebe5e8915

P932

Q33751565-6E9E4031-4C88-4E1D-9293-C3FC7999C627

P356

P1433

P1476

Increased toll-like receptor ( ...... osed type 2 diabetic subjects.

@en

P2093

Ishwarlal Jialal

http://www.w3.org/2001/XMLSchema#string

Mohan R Dasu

http://www.w3.org/2001/XMLSchema#string

Samuel Park

http://www.w3.org/2001/XMLSchema#string

Sridevi Devaraj

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation, stress, and diabetes

Toll-like receptors

TLR4 links innate immunity and fatty acid-induced insulin resistance

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

Endogenous ligands of Toll-like receptors.

Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome.

Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids.

Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state.

Endogenous TLR ligands and autoimmunity.

Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects.

P304

861-868

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC09-1799

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41000633

http://www.w3.org/2001/XMLSchema#string

P698

20067962

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

2845042

http://www.w3.org/2001/XMLSchema#string